Coexistence of an Endocrine Tumour in a Serous Cystadenoma (Microcystic Adenoma) of the Pancreas, an Unusual Association

Total Page:16

File Type:pdf, Size:1020Kb

Coexistence of an Endocrine Tumour in a Serous Cystadenoma (Microcystic Adenoma) of the Pancreas, an Unusual Association 800 J Clin Pathol 2000;53:800–802 Coexistence of an endocrine tumour in a serous cystadenoma (microcystic adenoma) of the pancreas, an unusual association M Ö Üstün, N Tug˘yan, M Tunakan Abstract within the head and the body of the pancreas. A pancreatic endocrine tumour arising Invasion to adjacent structures was not seen. within a serous cystadenoma is reported. There was central scarring with calcifications A 49 year old woman was admitted with a in the central region of the mass. Biochemical history of epigastric pain, nausea, vomit- analyses including amylase and bilirubin were ing, and weight loss of two months within the normal ranges except for raised duration. She had been diabetic for 12 alkaline phosphatase (1786 U/litre; normal years. An epigastric mass was palpated in range, 64–306) and alanine aminotransferase the physical examination, and computed (190 U/litre; normal range, 4–37). In addition, tomography revealed a multiloculated the patient was hyperglycaemic (fasting plasma cystic lesion in the pancreas. Pathological glucose concentration, 2770 mg/litre; normal examination of the pancreatic tumour range, 75–115). The clinical diagnosis was a revealed the coexistence of a serous cysta- cystic pancreatic neoplasm. A modified Whip- denoma and an endocrine tumour. The ple resection was performed and portions of endocrine tumour, which was located the small bowel (20 cm) and the proximal pan- inside the serous cystadenoma, was 1 cm creas (13 × 10 × 7 cm) were resected. Nearly in diameter. The first case of a serous cys- all of the resected pancreatic tissue was tadenoma of the pancreas containing a composed of a tan pink, multilocular cystic pancreatic endocrine tumour was re- neoplasm. A central stellate scar was present. ported in the literature recently. This The cystic spaces were filled with a clear fluid paper reports another incidentally found and ranged from 0.2 to 2.5 cm in diameter. pancreatic endocrine tumour arising The surgical specimen was fixed in 10% for- within a serous cystadenoma. malin and sections were stained with haema- ( 2000;53:800–802) J Clin Pathol toxylin and eosin, periodic acid SchiV (PAS), Keywords: pancreatic endocrine tumour; serous PAS with diastase, Alcian blue (pH 2.5), and cystadenoma; cystic neoplasms of the pancreas mucicarmine. Immunohistochemical studies were performed on paraYn wax embedded sections using a standard avidin–biotin– Serous cystadenomas, also known as micro- complex method with diaminobenzidine as the cystic adenomas or glycogen rich adenomas, chromogen. Commercially available mono- are benign tumours of the pancreas, which clonal antibodies against neuron specific eno- occur in elderly patients and have a slight lase (NSE; 1/50), chromogranin (1/100), female preponderance.12 These tumours are synaptophysin (1/10), epithelial membrane either discovered incidentally or present as an antigen (EMA; prediluted; Dako A/S, Den- abdominal mass with or without local pain. If mark), LEU 7 (1/25), gastrin (1/50), insulin the mass occurs in the pancreatic head, it can (1/500), glucagon (1/100), and somatostatin result in gastrointestinal or biliary tract ob- (1/50) were used. struction, and when suYcient islet cell tissue is Microscopic examination revealed multiple destroyed by the tumour, diabetes mellitus may cysts separated by fibrous connective septa. 1 also occur. Although these tumours usually Single layer cuboidal epithelial cells with bland arise in normal pancreas, rarely they are nucleus and clear or eosinophilic cytoplasm associated with other pancreatic neoplasms, 3 lined the cysts. PAS positive intracytoplasmic such as pancreatic ductal adenocarcinoma. material digested with diastase was consistent There is only one report in the literature on the Department of with glycogen (fig 1). Stains for mucin were coexistence of a pancreatic endocrine tumour negative in tumour cells. Although there were Pathology, Atatürk (PET) and a serous cystadenoma.4 In this arti- Teaching Hospital, micropapillary structures in some areas, necro- 35310 Izmir, Turkey cle, we report another patient presenting with a sis, nuclear atypia, and mitoses were absent. M Ö Üstün PET and a serous cystadenoma. Enlarged islets were seen under the cyst NTug˘yan, epithelium. The non-neoplastic pancreas was M Tunakan Case report normal in appearance; because serous cystad- Correspondence to: A 49 year old woman was admitted to hospital enomas usually grow slowly, the presence of Dr Üstün, Yahya Kaptan because of epigastric pain, nausea, vomiting, pancreatic islets within the tumours was an Postanesi, Posta Kutusu 2 1026, Kocaeli, Turkey and weight loss. She had a history of diabetes expected finding. In addition, enlargement of hasanustun@ mellitus for 12 years. Physical examination islets may accompany pancreatic endocrine netscape.net revealed a palpable epigastric mass. Computed neoplasms.5 Inside the central satellite scar, a Accepted for publication tomography scan showed a multiloculated microscopic focus of uniform cells in solid and 17 March 2000 cystic mass measuring 12 cm in diameter gyriform pattern was seen. At the periphery of www.jclinpath.com Short report 801 Discussion To our knowledge, a PET arising in association with a serous cystadenoma was described first by Keel et al in 1996. The patient was a 47 year old woman with a history of systemic lupus erythematosus who had been using steroids chronically for seven years.4 Our case presented here is a 49 year old woman with a history of diabetes mellitus for 12 years. From the embryological and histogenetic point of view, the potential of pancreatic ductal stem cells for biphasic diVerentiation along either glandular epithelial or neuroendocrine Figure 1 A single layer of cuboidal epithelium lines the pathways would not be unexpected. The pres- cysts. The periodic acid SchiV (PAS) reaction has ence of endocrine cells within exocrine carci- disappeared after diastase in the cyst epithelium (PAS with nomas has been reported previously in pancre- diastase). atic tumours.6 Pour et al evaluated the pancreatic carcinomas of Syrian golden ham- sters and reported a close relation between endocrine and ductal cells, pointing towards a common origin from a totipotent cell. Accord- ing to this study, pancreatic carcinogenesis was accompanied by the proliferation of ductular formations between islets (intrainsular duc- tules). First an adenomatous and cystadeno- matous pattern and then adenocarcinoma developed within pre-existing ductules, and within the newly formed intrainsular ductules. Simultaneously, during the process islets had gradually atrophied, but their remnants could be detected within the thin connective tissue septa of the cystadenomatous pattern. These findings suggest that both exocrine and endo- crine components of the pancreas might have the same origin—the multipotential stem cell of the ductal epithelium, which originates from the endodermal epithelium.7 Biphasic diVerentiation is seen in some pan- creatic disorders, either benign or malignant.8–10 Nesidioblastosis is another ex- ample of the close histogenetic relation be- tween the exocrine and endocrine pancreas. An unusual case of pancreatic carcinoma with both adenocarcinomatous and islet cell diVer- entiation, along with ultrastructural evidence Figure 2 The periphery of the pancreatic endocrine tumour is surrounded by cyst epithelium (haematoxylin and of focal acinar diVerentiation, has also been eosin stained section). described.9 Pancreatoblastoma appears to be the coun- the tumour, these uniform cells were embed- terpart of childhood tumours that arise from ded in stroma as single cell lines. Cells were stem cells in other organs. Both endocrine and small with scant eosinophilic cytoplasm and exocrine diVerentiation have been identified in stippled nuclei, consistent with endocrine cells. component cells such that ductal, acinar, and The solid endocrine tumour focus was sur- islet cells may be seen at the histological, rounded completely by the serous cystad- immunohistochemical, and ultrastructural enoma (fig 2). Immunohistochemical examina- level.11 The acinar–endocrine cell tumour of tion revealed strong positive staining for EMA the pancreas is a rare mixed tumour reported within the serous cystadenoma component, only in one paediatric and one adult patient. It although no such staining was seen in the is sometimes impossible to diVerentiate acinar endocrine tumour component. In contrast, cell carcinomas from endocrine tumours by immunohistochemical staining for NSE, light microscopy because of the histological chromogranin, synaptophysin, LEU 7, insulin, similarities. The detection of both zymogen and glucagon was positive in the endocrine and neuroendocrine granules within the same tumour, whereas all were negative in the cyst cell by ultrastructural and enzymatic analyses epithelium. Focal and weak staining was seen in acinar–endocrine cell tumours suggests a for glucagon, whereas insulin staining was focal neoplastic proliferation of intermediate cells.810 but strong in intensity. Gastrin and somatosta- Similarly, simultaneous neuroendocrine gran- tin staining was not detected. ule formation concentrated in the basal pole or Although the diabetic status of the patient in the cytoplasmic processes with mucin did not change after the removal of the tumour, production have been described in amphicrine she was well one year after surgery. carcinomas (mucinous islet cell carcinomas). www.jclinpath.com 802 Short report These are rare neoplasms composed of both from
Recommended publications
  • Scientific Framework for Pancreatic Ductal Adenocarcinoma (PDAC)
    Scientific Framework for Pancreatic Ductal Adenocarcinoma (PDAC) National Cancer Institute February 2014 1 Table of Contents Executive Summary 3 Introduction 4 Background 4 Summary of the Literature and Recent Advances 5 NCI’s Current Research Framework for PDAC 8 Evaluation and Expansion of the Scientific Framework for PDAC Research 11 Plans for Implementation of Recommended Initiatives 13 Oversight and Benchmarks for Progress 18 Conclusion 18 Links and References 20 Addenda 25 Figure 1: Trends in NCI Funding for Pancreatic Cancer, FY2000-FY2012 Figure 2: NCI PDAC Funding Mechanisms in FY2012 Figure 3: Number of Investigators with at Least One PDAC Relevant R01 Grant FY2000-FY2012 Figure 4: Number of NCI Grants for PDAC Research in FY 2012 Awarded to Established Investigators, New Investigators, and Early Stage Investigators Table 1: NCI Trainees in Pancreatic Cancer Research Appendices Appendix 1: Report from the Pancreatic Cancer: Scanning the Horizon for Focused Invervention Workshop Appendix 2: NCI Investigators and Projects in PDAC Research 2 Scientific Framework for Pancreatic Ductal Carcinoma Executive Summary Significant scientific progress has been made in the last decade in understanding the biology and natural history of pancreatic ductal adenocarcinoma (PDAC); major clinical advances, however, have not occurred. Although PDAC shares some of the characteristics of other solid malignancies, such as mutations affecting common signaling pathways, tumor heterogeneity, development of invasive malignancy from precursor lesions,
    [Show full text]
  • Combined Goblet Cellcarcinoid and Mucinous Cystadenoma of The
    I Clin Pathol 1995;48:869-870 869 Combined goblet cell carcinoid and mucinous cystadenoma of the appendix J Clin Pathol: first published as 10.1136/jcp.48.9.869 on 1 September 1995. Downloaded from R K Al-Talib, C H Mason, J M Theaker Abstract Case reports Two cases of combined goblet cell car- CASE ONE cinoid and mucinous cystadenoma oc- An adherent pelvic appendix was resected with curring in the appendix are reported. The difficulty from a 54 year old woman admitted histogenesis of the goblet cell carcinoid for an interval appendicectomy, two months remains one of its most controversial as- after an attack of appendicitis. The appendix pects and the occurrence of both of these measured 60 x 15 mm and was irregular, dis- relatively uncommon tumours in the same torted and showed serosal fibrosis. On sec- organ may lend support to the unitary tioning, the tip of the appendix was distended stem cell hypothesis on the origin of this and a mucus containing diverticulum pen- tumour. Alternatively, this occurrence etrating the muscular wall of the appendix was may represent an example ofthe adenoma/ identified. carcinoma sequence. ( Clin Pathol 1995;48:869-870) Department of CASE TWO Histopathology, Keywords: Goblet cell carcinoid, mucinous cyst- A 64 year old woman was a Southampton adenoma, appendix, histogenesis. admitted with four University Hospitals month history of a dull ache in the right iliac NHS Trust, fossa which had become increasingly severe Southampton S09 4XY R K Al-Talib Goblet cell carcinoid is an uncommon tumour over the last week.
    [Show full text]
  • A Case of Renal Cell Carcinoma Metastasizing to Invasive Ductal Breast Carcinoma Tai-Di Chen, Li-Yu Lee*
    Journal of the Formosan Medical Association (2014) 113, 133e136 Available online at www.sciencedirect.com journal homepage: www.jfma-online.com CASE REPORT A case of renal cell carcinoma metastasizing to invasive ductal breast carcinoma Tai-Di Chen, Li-Yu Lee* Department of Pathology, Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Guishan Township, Taoyuan County, Taiwan, ROC Received 12 December 2009; received in revised form 20 May 2010; accepted 1 July 2010 KEYWORDS Tumor-to-tumor metastasis is an uncommon but well-documented phenomenon. We present breast carcinoma; a case of a clear cell renal cell carcinoma (RCC) metastasizing to an invasive ductal carcinoma invasive ductal (IDC)ofthebreast.A74-year-oldwomanwitha past history of clear cell RCC status after carcinoma; radical nephrectomy underwent right modified radical mastectomy for an enlarging breast renal cell carcinoma; mass 3 years after nephrectomy. Histological examination revealed a small focus with distinct tumor-to-tumor morphological features similar to clear cell RCC encased in the otherwise typical IDC. Immu- metastasis nohistochemical studies showed that this focus was positive for CD10 and vimentin, in contrast to the surrounding IDC, which was negative for both markers and positive for Her2/neu. Based on the histological and immunohistochemical features, the patient was diagnosed with metas- tasis of clear cell RCC to the breast IDC. To the best of our knowledge, this is the first reported case of a breast neoplasm as the recipient tumor in tumor-to-tumor metastasis. Copyright ª 2012, Elsevier Taiwan LLC & Formosan Medical Association. All rights reserved. Introduction tumor is renal cell carcinoma (RCC, 38.8%), followed by meningioma (25.4%), and the most frequent donor tumor is The phenomenon of tumor-to-tumor metastasis was first lung cancer (55.8%).
    [Show full text]
  • Germline Fumarate Hydratase Mutations in Patients with Ovarian Mucinous Cystadenoma
    European Journal of Human Genetics (2006) 14, 880–883 & 2006 Nature Publishing Group All rights reserved 1018-4813/06 $30.00 www.nature.com/ejhg SHORT REPORT Germline fumarate hydratase mutations in patients with ovarian mucinous cystadenoma Sanna K Ylisaukko-oja1, Cezary Cybulski2, Rainer Lehtonen1, Maija Kiuru1, Joanna Matyjasik2, Anna Szyman˜ska2, Jolanta Szyman˜ska-Pasternak2, Lars Dyrskjot3, Ralf Butzow4, Torben F Orntoft3, Virpi Launonen1, Jan Lubin˜ski2 and Lauri A Aaltonen*,1 1Department of Medical Genetics, Biomedicum Helsinki, University of Helsinki, Helsinki, Finland; 2International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland; 3Department of Clinical Biochemistry, Aarhus University Hospital, Skejby, Denmark; 4Pathology and Obstetrics and Gynecology, University of Helsinki, Helsinki, Finland Germline mutations in the fumarate hydratase (FH) gene were recently shown to predispose to the dominantly inherited syndrome, hereditary leiomyomatosis and renal cell cancer (HLRCC). HLRCC is characterized by benign leiomyomas of the skin and the uterus, renal cell carcinoma, and uterine leiomyosarcoma. The aim of this study was to identify new families with FH mutations, and to further examine the tumor spectrum associated with FH mutations. FH germline mutations were screened from 89 patients with RCC, skin leiomyomas or ovarian tumors. Subsequently, 13 ovarian and 48 bladder carcinomas were analyzed for somatic FH mutations. Two patients diagnosed with ovarian mucinous cystadenoma (two out of 33, 6%) were found to be FH germline mutation carriers. One of the changes was a novel mutation (Ala231Thr) and the other one (435insAAA) was previously described in FH deficiency families. These results suggest that benign ovarian tumors may be associated with HLRCC.
    [Show full text]
  • Pancreatic Incidentalomas: Review and Current Management Recommendations
    Published online: 03.10.2019 THIEME 6 PancreaticReview Article Incidentalomas Surekha, Varshney Pancreatic Incidentalomas: Review and Current Management Recommendations Binit Sureka1 Vaibhav Varshney2 1Department of Diagnostic and Interventional Radiology, All India Address for correspondences Binit Sureka, MD, DNB, MBA, Institute of Medical Sciences, Jodhpur, Rajasthan, India Department of Diagnostic and Interventional Radiology, All 2Department of Surgical Gastroenterology, All India Institute of India Institute of Medical Sciences, Basni Industrial Area, Medical Sciences, Jodhpur, Rajasthan, India MIA 2nd Phase, Basni, Jodhpur 342005, Rajasthan, India (e-mail: [email protected]). Ann Natl Acad Med Sci (India) 2019;55:6–13 Abstract There has been significant increase in the detection of incidental pancreatic lesions due to widespread use of cross-sectional imaging like computed tomography and magnet- ic resonance imaging supplemented with improvements in imaging resolution. Hence, Keywords accurate diagnosis (benign, borderline, or malignant lesion) and adequate follow-up ► duct is advised for these incidentally detected pancreatic lesions. In this article, we would ► incidentaloma review the various pancreatic parenchymal (cystic or solid) and ductal lesions (congen- ► pancreas ital or pathological), discuss the algorithmic approach in management of incidental ► pancreatic cyst pancreatic lesions, and highlight the key imaging features for accurate diagnosis. Introduction MPD. The second aim is to further classify the lesion
    [Show full text]
  • Metastatic Renal Cell Cancer Presenting As a Breast Mass
    H & 0 C l i n i C a l C a s e s t u d i e s Metastatic Renal Cell Cancer Presenting as a Breast Mass Neeta Pathe, MD Department of Hematology and Oncology, Allegheny General Hospital, Jane Raymond, MD Pittsburgh, Pennsylvania Alice Ulhoa Cintra, MD introduction a focus of residual DCIS extending to the lateral resec- tion margin. The 2 sentinel lymph nodes examined Metastases to the breast are uncommon, and demand an were benign. Two weeks after her surgery, the patient accurate and prompt diagnosis due to differences in prog- complained of increased swelling on the medial side of nosis and management from primary breast cancer. Here the left breast. This swelling was re-evaluated by a repeat we describe a case of renal cell cancer metastasizing to the ultrasound, which showed an unchanged size of the oval breast 10 years after nephrectomy for the primary tumor. mass and mixed echogenicity. Historically, the prognosis for such a patient has been Preoperatively, a chest X-ray revealed a 6-mm right extremely poor. In the era of novel therapies, however, we lung nodule, and a computed tomography (CT) scan was are now able to provide treatment with an oral agent and recommended for follow-up. The CT scan of the chest, achieve an excellent response. which was performed approximately 3 months after the right lumpectomy, revealed multiple bilateral pulmonary Case study nodules measuring 4–5 mm. Additionally, the lesion in the left breast had increased to 2.7 × 1.9 cm and was suspicious A 64-year-old African American woman with a history for metastatic disease (Figure 1).
    [Show full text]
  • Large Duct Type Invasive Adenocarcinoma of the Pancreas with Microcystic and Papillary Patterns: a Potential Microscopic Mimic of Non-Invasive Ductal Neoplasia
    Modern Pathology (2012) 25, 439–448 & 2012 USCAP, Inc. All rights reserved 0893-3952/12 $32.00 439 Large duct type invasive adenocarcinoma of the pancreas with microcystic and papillary patterns: a potential microscopic mimic of non-invasive ductal neoplasia Pelin Bagci1, Aleodor A Andea2, Olca Basturk3, Kee-Taek Jang4,IpekErbarut5 and Volkan Adsay5 1Department of Pathology, Rize University, School of Medicine, Rize, Turkey; 2Department of Pathology, University of Alabama at Birmingham, Birmingham, AL, USA; 3Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York City, NY, USA; 4Department of Pathology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea and 5Department of Pathology, Emory University, Atlanta, GA, USA A morphological variant of pancreatic ductal adenocarcinoma forming large ductal elements, large duct type ductal adenocarcinoma, is documented and its clinicopathological features are studied. These tumors may have microcystic and papillary growth patterns that closely mimic the non-invasive cystic and papillary pancreatic tumors such as: intraductal papillary-mucinous neoplasia, including the oncocytic variant, mucinous cystic neoplasms, and ducts involved by pancreatic intraepithelial neoplasia. In a review of 230 pancreatectomy specimens with ductal adenocarcinoma, 28 (8%) cases of large duct type ductal adenocarcinomas were identified according to following criteria: more than 50% of the tumor sections available for examination contained infiltrative ducts with a diameter larger than 0.5 mm or had a macroscopically identifiable microcystic pattern. Overall characteristics of large duct type ductal adenocarcinomas were not too different than those of conventional ductal adenocarcinomas, except that there was a slight female predominance in the former (F/M ¼ 2.3).
    [Show full text]
  • Liver, Gallbladder, Bile Ducts, Pancreas
    Liver, gallbladder, bile ducts, pancreas Coding issues Otto Visser May 2021 Anatomy Liver, gallbladder and the proximal bile ducts Incidence of liver cancer in Europe in 2018 males females Relative survival of liver cancer (2000 10% 15% 20% 25% 30% 35% 40% 45% 50% 0% 5% Bulgaria Latvia Estonia Czechia Slovakia Malta Denmark Croatia Lithuania N Ireland Slovenia Wales Poland England Norway Scotland Sweden Netherlands Finland Iceland Ireland Austria Portugal EUROPE - Germany 2007) Spain Switzerland France Belgium Italy five year one year Liver: topography • C22.1 = intrahepatic bile ducts • C22.0 = liver, NOS Liver: morphology • Hepatocellular carcinoma=HCC (8170; C22.0) • Intrahepatic cholangiocarcinoma=ICC (8160; C22.1) • Mixed HCC/ICC (8180; TNM: C22.1; ICD-O: C22.0) • Hepatoblastoma (8970; C22.0) • Malignant rhabdoid tumour (8963; (C22.0) • Sarcoma (C22.0) • Angiosarcoma (9120) • Epithelioid haemangioendothelioma (9133) • Embryonal sarcoma (8991)/rhabdomyosarcoma (8900-8920) Morphology*: distribution by sex (NL 2011-17) other other ICC 2% 3% 28% ICC 56% HCC 41% HCC 70% males females * Only pathologically confirmed cases Liver cancer: primary or metastatic? Be aware that other and unspecified morphologies are likely to be metastatic, unless there is evidence of the contrary. For example, primary neuro-endocrine tumours (including small cell carcinoma) of the liver are extremely rare. So, when you have a diagnosis of a carcinoid or small cell carcinoma in the liver, this is probably a metastatic tumour. Anatomy of the bile ducts Gallbladder
    [Show full text]
  • Enlarging Nodule on the Nipple
    PHOTO CHALLENGE Enlarging Nodule on the Nipple Caren Waintraub, MD; Brianne Daniels, DO; Shari R. Lipner, MD, PhD Eligible for 1 MOC SA Credit From the ABD This Photo Challenge in our print edition is eligible for 1 self-assessment credit for Maintenance of Certification from the American Board of Dermatology (ABD). After completing this activity, diplomates can visit the ABD website (http://www.abderm.org) to self-report the credits under the activity title “Cutis Photo Challenge.” You may report the credit after each activity is completed or after accumulating multiple credits. A healthy 48-year-old woman presented with a growth on the right nipple that had been slowly enlarging over the last few months. She initially noticed mild swellingcopy in the area that persisted and formed a soft lump. She described mild pain with intermittent drainage but no bleeding. Her medical history was unremarkable, including a negativenot personal and family history of breast and skin cancer. She was taking no medications prior to development of the mass. She had no recent history of pregnancy or breastfeeding. A mammo- Dogram and breast ultrasound were not concerning for carcinoma. Physical examination showed a soft, exophytic, mildly tender, pink nodule on the right nipple that measured 12×7 mm; no drainage, bleeding, or ulceration was present. The surround- ing skin of the areola and breast demonstrated no clinical changes. The contralateral breast, areola, and nipple were unaffected. The patient had no appreciable axillary or cervical lymphadenopathy. A deep shave biopsy of the noduleCUTIS was performed and sent for histopathologic examination.
    [Show full text]
  • Co-Existent Breast and Renal Cancer
    Ulus Cerrahi Derg 2015; 31: 238-40 Case Report DOI: 10.5152/UCD.2015.2874 Co-existent breast and renal cancer Orhan Üreyen1, Emrah Dadalı1, Fırat Akdeniz2, Tamer Şahin3, Mehmet Tahsin Tekeli1, Nuket Eliyatkın3, Hakan Postacı3, Enver İlhan1 ABSTRACT The concomitant presence of breast cancer with one or more other types of cancer such as colon, vulva, lung, larynx, liver, uterus and kidneys has been presented in the literature. However, synchronous breast and renal cancer is very uncommon. Herein we present a woman with synchronous breast and renal cancer, and review the literature. A 77-year-old post-menopausal woman was admitted to our clinic complaining of left sided breast mass. On physical examination, there was a 3 cm palpable mass in the upper outer quadrant of the left breast along with a conglom- erate of lymph nodes in the left axilla. Ultrasonography and mammography showed a 3 cm solid, hypoechoic mass in the upper outer quadrant and left axillary lymphadenopathy. The tru-cut biopsy of the lesion revealed invasive ductal carcinoma. The bone scintigraphy, thoracic and cranial computerized tomographies were normal. The ab- dominal computerized tomography identified a 3x3 cm solid renal mass with heterogeneous contrast enhancement in the posterior segment of the lower pole, which was suspicious for renal cell carcinoma. Breast conserving surgery and axillary lymph node dissection was performed, and the pathology specimen demonstrated invasive ductal car- cinoma. The patient was discharged on postoperative day 5. Three weeks later partial nephrectomy was performed by urology department for the solid renal mass, and the pathology result showed clear cell-renal carcinoma with Fuhrman grade 3.
    [Show full text]
  • Ductal Carcinoma in Situ
    Breast Cancer Definition of Ductal Carcinoma In Situ Terms What is Ductal Carcinoma What characterizes DCIS? Ductal: Relating In Situ (DCIS)? DCIS is characterized by pre-can- to the breast’s milk Ductal Carcinoma In Situ is the cerous or early-stage cell abnor- ducts, the parts of the earliest possible and most treat- malities in the breast ducts. On a breast through which able diagnosis of breast cancer. mammogram, DCIS appears as milk fl ows. Some experts consider it to be areas of calcifi cation. “pre-malignant.” The most com- Carcinoma: A type mon form of non-invasive breast How does the pathologist of cancerous, or ma- cancer, DCIS accounts for about make a diagnosis? lignant, tumor. 25 percent of all breast cancers. The pathologist examines biopsy Sometimes, DCIS is seen in as- specimens, In Situ: In its original sociation with an invasive form of along with place. breast cancer. other tests if The diagnosis of DCIS is in- necessary. If Non-invasive: Not spreading beyond the creasing because more women are mammogra- inside of the breast receiving regular mammograms phy shows duct. – and because of advancements in suspicious mammography technology, which fi ndings, a Calcifi cation: Cal- can now fi nd small areas of calci- biopsy may cium deposits in the fi cation in the breast. If untreated, be recom- breast can be associ- about 30 percent of women with mended. A ated with Ductal Car- DCIS will develop invasive breast biopsy is the Ductal Carcinoma cinoma In Situ. Clus- cancer within 10 years of the ini- most widely used method for In Situ is the earliest ters of these deposits tial making a fi rm diagnosis of breast possible and most may indicate cancer.
    [Show full text]
  • Adenoid Cystic Carcinoma of the Breast Law Y M, Quek S T, Tan P H, Wong S L J
    Case Report Singapore Med J 2009; 50(1) : e8 Adenoid cystic carcinoma of the breast Law Y M, Quek S T, Tan P H, Wong S L J ABSTRACT depressants. Family history was negative for breast Adenoid cystic carcinoma of the breast is a and ovarian cancer. Menarche occurred at the age of rare neoplasm that constitutes less than one 12 years and she attained menopause at the age of 50 percent of all mammary carcinomas. To date, years. She was placed on hormone replacement therapy there have been about 140 cases reported in the postmenopausally for a period of less than five years. literature. It is a rare variant of adenocarcinoma She was married with no children. She did not smoke that usually occurs in the salivary glands. In or drink. Physical examination revealed a vaguely contrast to the aggressive nature of adenoid palpable 1 cm mass at the upper outer quadrant of the cystic carcinoma that occurs in the head and neck right breast. There were no skin changes nor was there region, adenoid cystic carcinoma of the breast nipple discharge. No palpable axillary adenopathy was has a very favourable prognosis. Little has been detected. published to date on its radiological features. Mammography revealed an asymmetric ill-defined We describe a 63-year-old woman with adenoid mass in the upper outer quadrant of the right breast, cystic carcinoma detected on mammography in approximately 5 cm from the nipple (Fig. 1). The our national breast screening programme, the patient was recalled for an assessment of the abnormal radiological findings at presentation, the surgical mammography finding through the breast screening management and a review of the literature.
    [Show full text]